INCIDENCE AND OUTCOMES IN GLIOMAS FROM BRAIN TUMOR REGISTRY OF JAPAN 2001-2004

医学 间变性星形细胞瘤 毛细胞星形细胞瘤 胶质瘤 星形细胞瘤 内科学 脑瘤 入射(几何) 肿瘤科 胶质母细胞瘤 放射治疗 病历 病理 癌症研究 光学 物理
作者
Yusuke Narita,Soichiro Shibui
出处
期刊:Neuro-oncology [Oxford University Press]
卷期号:16 (suppl 3): iii3-iii3 被引量:1
标识
DOI:10.1093/neuonc/nou206.9
摘要

BACKGROUND: (blind field). METHODS: Data on primary or metastatic brain tumor cases that were newly diagnosed from 2001 to 2004 were collected from 2009 until the end of 2012. Approximately 330 neurosurgeons, medical doctors, and staff from 109 institutions collected 16,338 data from clinical records. These institutions included most universities, colleges, and hospitals with Japan Neurosurgical Society-authorized boards. These data were collected via the Internet Data and Information Center for Medical Research. Data, including the birthplace, age, tumor sites, diagnostic method, therapy (surgery, radiation, or chemotherapy), and the outcome of these treatments, according to the World Health Organization (WHO) 2007 brain tumor classification were collected. Survival data were analyzed using the Kaplan-Meier method. RESULTS: Overall survival (OS, months), progression free survival (PFS, months), 5-year OS, 5-year PFS of each grade of gliomas are as follows; pilocytic astrocytoma; NR (not reached), NR, 92.1%, 73.8%, diffuse astrocytoma: NR, 84.1, 75%, 57%, grade II oligodendroglial tumor: NR, NR, 90%, 74.6%, anaplastic astrocytoma: 38, 19, 41.1%, 28.7%, grade III anaplastic oligodendroglial tumor: NR, 71, 68.2%, 54%, glioblastoma: 15, 8.1, 10.1%, 9.2%. CONCLUSIONS: The 5-year OS of grade II and III gliomas improved compared to that in 1997-2000 but that of glioblastoma did not. Based on the data of BTRJ 2001-2004, trends and problems in treatment and outcomes of gliomas will be presented and discussed. SECONDARY CATEGORY: n/a.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zh发布了新的文献求助10
1秒前
量子星尘发布了新的文献求助10
1秒前
早日毕业完成签到,获得积分10
1秒前
2秒前
2秒前
桐桐应助呼之欲出采纳,获得10
2秒前
漂亮的青荷完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
小白完成签到,获得积分10
8秒前
饱满南松发布了新的文献求助10
9秒前
10秒前
无花果应助毅然决然必然采纳,获得10
10秒前
11秒前
白小白发布了新的文献求助10
12秒前
Dream发布了新的文献求助10
13秒前
13秒前
萨柏斯塔完成签到,获得积分10
14秒前
Hello应助饱满南松采纳,获得10
14秒前
SYLH应助ff采纳,获得30
15秒前
上官若男应助典雅煎蛋采纳,获得10
16秒前
will_fay发布了新的文献求助10
16秒前
17秒前
17秒前
18秒前
木炭完成签到,获得积分10
20秒前
小蘑菇应助科研通管家采纳,获得10
20秒前
搜集达人应助科研通管家采纳,获得10
20秒前
20秒前
彭于晏应助科研通管家采纳,获得10
20秒前
20秒前
20秒前
20秒前
20秒前
852应助ssw采纳,获得10
21秒前
21秒前
will_fay完成签到,获得积分10
21秒前
慕青应助hhh采纳,获得10
22秒前
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975722
求助须知:如何正确求助?哪些是违规求助? 3520056
关于积分的说明 11200719
捐赠科研通 3256455
什么是DOI,文献DOI怎么找? 1798271
邀请新用户注册赠送积分活动 877490
科研通“疑难数据库(出版商)”最低求助积分说明 806390